‘ANNEX

GENERAL INTRODUCTION

1. GENERAL PRINCIPLES

1.1. The objective of the principles developed in this Annex is to ensure a high level of protection of human and animal (species normally fed and kept by humans or food-producing animals) health and the environment in evaluations and decisions by Member States with regard to authorisation of plant protection products, implementing the requirements of Article 29(1)(e) in conjunction with Article 4(3) and Article 29(1)(f), (g) and (h) of Regulation (EC) No 1107/2009. For the purpose of this Annex, the following definitions apply: (1) ‘efficacy’ means a measure concerning the overall effect of the application of a plant protection product on the agricultural system in which it is used (i.e. which includes positive effects of treatment in performing the desired plant protection activity and negative effects such as development of resistance, phytotoxicity or reduction of qualitative or quantitative yield); (2) ‘relevant impurity’ means a chemical impurity that is of concern for human health, animal health or the environment; (3) ‘storage stability’ means the capacity of a plant protection product to maintain the initial properties and the specified content during the storage period under established storage conditions.

1.2. In evaluating applications for granting authorisations Member States shall: (a) — ensure that dossiers supplied are in accordance with the requirements of the Annex to Commission Regulation (EU) No 284/2013 (1), at the latest at the time of finalisation of the evaluation for the purpose of decision-making, without prejudice, where relevant, to Articles 33, 34 and 59 of Regulation (EC) No 1107/2009, — ensure that the data submitted by the applicant are acceptable in terms of quantity, quality, consistency and reliability and sufficient to permit a proper evaluation of the dossier, — evaluate, where relevant, justifications submitted by the applicant for not supplying certain data; (b) take into account the data concerning the active substance in the plant protection product of the Annex to Commission Regulation (EU) No 283/2013 (2), submitted for the purpose of approval of the active substance under Regulation (EC) No 1107/2009, and the results of the evaluation of those data, without prejudice, where relevant, to the provisions of Article 33(3) and of Articles 34 and 59 of Regulation (EC) No 1107/2009; (c) take into consideration other relevant technical or scientific information with regard to the efficacy of the plant protection product or to the potentially adverse effects of the plant protection product its components or its residues, where relevant.

1.3. Where, in the specific principles on evaluation, reference is made to the data of the Annex to Regulation (EU) No 283/2013 this shall be understood as being the data referred to in point 1.2(b) of this Annex.

1.4. Where the data and information provided are sufficient to permit completion of the evaluation for one of the proposed uses, Member States shall evaluate applications and make a decision for the proposed use. Taking account of justifications provided and with the benefit of any subsequent clarifications, Member States shall reject applications for granting authorisations for which the data gaps are such that it is not possible to finalise the evaluation and to make a reliable decision for at least one of the proposed uses.

1.5. During the process of evaluation and decision-making, Member States shall cooperate with the applicants in order to resolve any questions on the dossier quickly or to identify at an early stage any additional studies necessary for a technically complete dossier that allows for a proper evaluation, or to amend any proposed conditions for the use of the plant protection product or to modify its nature or its composition in order to ensure full compliance with the requirements of this Annex and more generally with the provisions of Regulation (EC) No 1107/2009.

1.6. During the process of evaluation and decision-making, Member States shall base their assessment on scientific principles, preferably recognised at international level, and this process shall be made with the benefit of expert advice.

1.7. Member States shall take into account those guidance documents applicable at the date of the submission of the application for the authorisation.

2. EVALUATION, GENERAL PRINCIPLES

2.1. Having regard to current scientific and technical knowledge, Member States shall evaluate the information referred to in point 1.2, and in particular: (a) identify the risks arising, assess their significance and the expected exposure, and make a judgement as to the likely risks to humans, animals or the environment; (b) assess efficacy in terms of effectiveness (including possible development of resistance or cross-resistance of the target organism(s)) and adverse effects (including phytotoxicity/pathogenicity) on crops (including treated crops, succeeding crops and adjacent crops) of the plant protection product for each use for which authorisation is sought.

2.2. Member States shall evaluate the quality and the methodology of tests, especially where there are no standardised test methods, as well as the following characteristics of the methods described, when available: relevance; representativeness; sensitivity; specificity; reproducibility.

2.3. In interpreting the results of evaluations, Member States shall take into consideration and report possible elements of uncertainty in the information obtained during the evaluation, in order to ensure that the chances of failing to detect adverse effects or of underestimating their importance are reduced to a minimum. The decision-making process shall be examined to identify critical decision points or items of data for which uncertainties could lead to a false classification of risk.

2.4. In accordance with Article 29 of Regulation (EC) No 1107/2009, Member States shall ensure that evaluations carried out have regard to the proposed practical conditions of use and, in particular, to the purpose of use, the application dose, the application method, frequency and timing of applications, and the nature and composition of the plant protection product. In accordance with the requirements for proper use as set out in Article 55 of Regulation (EC) No 1107/2009, Member States shall take into account the provisions of Directive 2009/128/EC of the European Parliament and of the Council (3) and, in particular, the principles of integrated pest management.

2.5. In the evaluation, Member States shall consider the agricultural, plant health or environmental (including climatic) conditions in the areas of use.

2.6. Where specific principles in Section 1 of Part A or Section 1 of Part B (as applicable) provide for the use of calculation models in the evaluation of a plant protection product, those models shall: (a) make a best possible estimation in an appropriate way of all relevant processes involved taking into account realistic parameters and assumptions; (b) be submitted to an evaluation as referred to in point 2.3; (c) be reliably validated with measurements carried out under circumstances relevant for the use of the model; (d) be relevant to the conditions in the area of use; (e) in cases the models have not been validated, be supported with details indicating how the model calculates estimates provided, and explanations of all the inputs to the model and details of how they have been derived.

2.7. Where metabolites are referred to in the specific principles, only those that are relevant for the proposed criterion shall be taken into consideration. For Part A this concerns also degradation or reaction products. For Part B this concerns what is defined as “metabolites of concern”.

3. DECISION-MAKING, GENERAL PRINCIPLES

3.1. Where appropriate, Member States shall impose conditions or restrictions on the authorisations they grant. The nature and severity of these conditions or restrictions shall be selected on the basis of, and be appropriate to, the nature and extent of the expected advantages and the risks likely to arise.

3.2. Member States shall ensure that decisions taken to grant authorisations take account of the agricultural, plant health or environmental (including climatic) conditions in the areas of envisaged use. Such considerations may result in specific conditions and restrictions on use, and in authorisation being granted for some but not other areas within the Member State in question.

3.3. Member States shall ensure that the authorised application rates and number of applications, are the minimum necessary to achieve the desired effect even where higher rates would not result in unacceptable risks to human or animal health or to the environment. The authorised rates shall be differentiated in accordance with, and be appropriate to, the agricultural, plant health or environmental (including climatic) conditions in the various areas for which an authorisation is granted. However, the application rates and the number of applications may not give rise to undesirable effects such as the development of resistance in the target organism.

3.4. Member States shall ensure that decisions taken to grant authorisations consider integrated pest management as set out in Directive 2009/128/EC. In particular, Member States shall ensure that a warning phrase is indicated on the label in case negative effects are expected on beneficial organisms that are deliberately released as part of integrated pest management strategies.

3.5. Since the evaluation is to be based on data concerning a limited number of representative non-target species, Member States shall ensure that use of plant protection products does not have any long-term repercussions for the abundance and diversity of non-target species.

3.6. Before issuing an authorisation, Member States shall ensure that the label of the plant protection product: (a) fulfils the requirements setting out in Regulation (EU) No 547/2011; (b) also contains the information on protection of operators, workers, bystanders and residents required by EU legislation on worker protection; (c) specifies in particular the conditions or restrictions under which the plant protection product may or may not be used as referred to in points 3.1 to 3.5 of this general introduction. The authorisation shall mention the particulars indicated in Regulation (EC) No 1272/2008 of the European Parliament and of the Council (4).

3.7. Before issuing authorisations, Member States shall: (a) ensure that the proposed packaging is in accordance with the provisions of Regulation (EC) No 1272/2008; (b) ensure that the following procedures are in accordance with the relevant regulatory provisions: — the procedures for destruction of the plant protection product, — the procedures for neutralisation of any adverse effects of the plant protection product if it is accidentally dispersed, and — the procedures for the decontamination and destruction of the packaging.

3.8. No authorisation shall be granted unless all the requirements referred to in Section 2 of Part A or Section 2 of Part B (as applicable) are satisfied. However: (a) when one or more of the specific decision-making requirements referred to in points 2.1, 2.2, 2.3 or 2.7 of Part A, or point 2.3 of Part B, respectively, are not satisfied, authorisations shall be granted only where the advantages of the use of the plant protection product under the proposed conditions of use outweigh the possible adverse effects of its use. Any restrictions on use of the plant protection product relating to non-compliance with some of the aforementioned requirements must be mentioned on the label, and non-compliance with the requirements referred to in point 2.7 of Part A (if Part A applies) shall not compromise proper use of the plant protection product. These advantages can be in terms of: — advantages for and compatibility with integrated control measures or organic farming, — facilitating strategies to minimise the risk of development of resistance, — the need for a greater diversity of types of active substances or biochemical modes of action, e.g. for use in strategies to avoid accelerated breakdown in the soil, — reduced risk for operators and consumers, — reduced contamination of the environment and reduced impact on non-target species. (b) where the criteria referred to in point 2.6 of Part A or point 2.4 of Part B, respectively, are not fully satisfied because of limitations in current analytical science and technology, authorisation shall be granted for a limited period if the methods submitted prove adequate for the purposes intended. In this case, the applicant shall be required to develop and submit analytical methods that are in accordance with those criteria by a specific deadline. The authorisation shall be reviewed on expiry of that deadline; (c) where the reproducibility of the submitted analytical methods referred to in point 2.6 of Part A or point 2.4 of Part B, respectively has only been verified in two laboratories, an authorisation shall be granted for 1 year to permit the applicant to demonstrate the reproducibility of those methods in accordance with agreed criteria in at least a third laboratory.

3.9. Where an authorisation has been granted in accordance with the requirements provided for in this Annex, Member States may, by virtue of Article 44 of Regulation (EC) No 1107/2009: (a) define, where possible, preferably in close cooperation with the applicant, measures to improve the efficacy of the plant protection product; and/or (b) define, where possible, in close cooperation with the applicant, measures to reduce further the exposure that could occur during and after use of the plant protection product. Member States shall inform applicants of any measures identified under (a) or (b) and shall require applicants to provide any supplementary data and information necessary to demonstrate efficacy or acceptability of risks arising under the changed conditions.

3.10. Member States shall ensure, as far as it is practically possible, that for all active substances contained in plant protection products that are considered for an authorisation, the applicant has taken into account all available relevant knowledge and information in scientific literature at the time of submission of the dossier on the plant protection product.

PART A

Uniform principles for evaluation and authorisation of chemical plant protection products

1. EVALUATION

Member States shall, for the evaluation of the data and information submitted in support of applications, and without prejudice to the general principles of Section 2 of the general introduction, implement the following principles.

1.1. Efficacy

1.1.1. Where the proposed use concerns the control of or protection against an organism, Member States shall evaluate the possibility that this organism could be harmful under the agricultural, plant health and environmental (including climatic) conditions in the area of the proposed use.

1.1.2. Where the proposed use concerns an effect other than the control of or protection against an organism, Member States shall evaluate whether significant damage, loss or inconvenience could occur under the agricultural, plant health and environmental (including climatic) conditions in the area of proposed use if the plant protection product were not used.

1.1.3. Member States shall evaluate the efficacy data on the plant protection product as provided for in the Annex to Regulation (EU) No 284/2013 having regard to the degree of control or the extent of the effect desired and having regard to the relevant experimental conditions such as: — the choice of the crop or cultivar, — the agricultural and environmental (including climatic) conditions, — the presence and density of the harmful organism, — the development stage of crop and organism, — the amount of the plant protection product used, — if required on the label, the amount of adjuvant added, — the frequency and timing of the applications, — the type of application equipment.

1.1.4. Member States shall evaluate the performance of the plant protection product in a range of agricultural, plant health and environmental (including climatic) conditions likely to be encountered in practice in the area of proposed use and in particular: (i) the level, consistency and duration of the effect sought in relation to the dose in comparison with a suitable reference product or products and an untreated control; (ii) where relevant, effect on yield or reduction of loss in storage, in terms of quantity and/or quality, in comparison with a suitable reference product or products and an untreated control. Where no suitable reference product exists, Member States shall evaluate the performance of the plant protection product to determine whether there is a consistent and defined benefit under the agricultural, plant health and environmental (including climatic) conditions in the area of proposed use.

1.1.5. Where the product label includes requirements for use of the plant protection product with other plant protection products and/or with adjuvants as a tank mix, Member States shall make the evaluations referred to in points 1.1.1 to 1.1.4 in relation to the information supplied for the tank mix. Where the product label includes recommendations for use of the plant protection product with other plant protection products and/or with adjuvants as a tank mix, Member States shall evaluate the appropriateness of the mix and of its conditions of use.

1.2. Absence of unacceptable effects on plants or plant products

1.2.1. Member States shall evaluate the degree of adverse effects on the treated crop after use of the plant protection product in accordance with the proposed conditions of use in comparison, where relevant, with a suitable reference product or products, where they exist, and/or an untreated control. (a) This evaluation shall take into consideration the following information: (i) the efficacy data provided for in the Annex to Regulation (EU) No 284/2013; (ii) other relevant information on the plant protection product such as nature of the preparation, dose, method of application, number and timing of applications; (iii) all relevant information on the active substance as provided for in of the Annex to Regulation (EU) No 283/2013, including mode of action, vapour pressure, volatility and water solubility. (b) This evaluation shall include: (i) the nature, frequency, level and duration of observed phytotoxic effects and the agricultural, plant health and environmental (including climatic) conditions that affect them; (ii) the differences between main cultivars with regard to their sensitivity to phytotoxic effects; (iii) the part of the treated crop or plant products where phytotoxic effects are observed; (iv) the adverse impact on the yield of the treated crop or plant products in terms of quantity and/or quality; (v) the adverse impact on treated plants or plant products to be used for propagation, in terms of viability, germination, sprouting, rooting and establishment; (vi) where volatile products are concerned, the adverse impact on adjacent crops.

1.2.2. Where the available data indicate that the active substance or significant metabolites, degradation and reaction products persist in soils and/or in or on plant substances in significant quantities after use of the plant protection product in accordance with the proposed conditions of use, Member States shall evaluate the degree of adverse effects on subsequent crops. This evaluation shall be carried out as specified in point 1.2.1.

1.2.3. Where the product label includes requirements for use of the plant protection product with other plant protection products or with adjuvants as a tank mix, the evaluation as specified in point 1.1.1 shall be carried out in relation to the information supplied for the tank mix.

1.3. Impact on vertebrates to be controlled

Where the proposed use of the plant protection product aims to have an effect on vertebrates, Member States shall evaluate the mechanism by which this effect is obtained and the observed effects on the behaviour and health of the target animals; when the intended effect is to kill the target animal they shall evaluate the time necessary to obtain the death of the animal and the conditions under which death occurs.

This evaluation shall take into consideration the following information:

(i) all relevant information as provided for in the Annex to Regulation (EU) No 283/2013 and the results of the evaluation thereof, including the toxicological and metabolism studies;

(ii) all relevant information on the plant protection product as provided for in the Annex to Regulation (EU) No 284/2013, including toxicological studies and efficacy data.

1.4. Impact on human or animal health

1.4.1. Impact on human or animal health arising from the plant protection product

1.4.1.1. Member States shall evaluate operator exposure to the active substance and/or to toxicologically relevant compounds in the plant protection product likely to occur under the proposed conditions of use (including in particular dose, application method and climatic conditions) using by preference realistic data on exposure and, if such data are not available, a suitable, validated calculation model. (a) This evaluation shall take into consideration the following information: (i) the toxicological and metabolism studies as provided for in the Annex to Regulation (EU) No 283/2013 and the results of the evaluation thereof including the acceptable operator exposure level (AOEL). The acceptable operator exposure level is the maximum amount of active substance to which the operator may be exposed without any adverse health effects. The AOEL is expressed as milligrams of the chemical per kilogram body weight of the operator. The AOEL is based on the highest level at which no adverse effect is observed in tests in the most sensitive relevant animal species or, if appropriate data are available, in humans; (ii) other relevant information on the active substances such as physical and chemical properties; (iii) the toxicological studies provided for in the Annex to Regulation (EU) No 284/2013, including where appropriate dermal absorption studies; (iv) other relevant information as provided for in the Annex to Regulation (EU) No 284/2013 such as: — composition of the preparation, — nature of the preparation, — size, design and type of packaging, — field of use and nature of crop or target, — method of application including handling, loading and mixing of product, — exposure reduction measures recommended, — protective clothing recommendations, — maximum application rate, — minimum spray application volume stated on the label, — number and timing of applications. (b) This evaluation shall be made for each type of application method and application equipment proposed for use of the plant protection product as well as for the different types and sizes of containers to be used, taking account of mixing, loading operations, application of the plant protection product and cleaning and routine maintenance of application equipment.

1.4.1.2. Member States shall examine information relating to the nature and characteristics of the packaging proposed with particular reference to the following aspects: — the type of packaging, — its dimensions and capacity, — the size of the opening, — the type of closure, — its strength, leakproofness and resistance to normal transport and handling, — its resistance to and compatibility with the contents.

1.4.1.3. Member States shall examine the nature and characteristics of the protective clothing and equipment proposed with particular reference to the following aspects: — obtainability and suitability, — ease of wearing taking into account physical stress and climatic conditions.

1.4.1.4. Member States shall evaluate the possibility of exposure of other humans (bystanders or workers exposed after the application of the plant protection product) or animals to the active substance and/or to other toxicologically relevant compounds in the plant protection product under the proposed conditions of use. This evaluation shall take into consideration the following information: (i) the toxicological and metabolism studies on the active substance as provided for in the Annex to Regulation (EU) No 283/2013 and the results of the evaluation thereof, including the acceptable operator exposure level; (ii) the toxicological studies provided for in the Annex to Regulation (EU) No 284/2013, including where appropriate dermal absorption studies; (iii) other relevant information on the plant protection product as provided for in the Annex to Regulation (EU) No 284/2013 such as: — re-entry periods, necessary waiting periods or other precautions to protect humans and animals, — method of application, in particular spraying, — maximum application rate, — maximum spray application volume, — composition of the preparation, — excess remaining on plants and plant products after treatment, — further activities whereby workers are exposed.

1.4.2. Impact on human and animal health arising from residues

1.4.2.1. Member States shall evaluate the specific information on toxicology as provided for in the Annex to Regulation (EU) No 283/2013 and in particular: — the determination of an acceptable daily intake (ADI), — the identification of metabolites, degradation and reaction products in treated plants or plant products, — behaviour of residues of the active substance and its metabolites from the time of application until harvest, or in the case of postharvest uses, until outloading of stored plant products.

1.4.2.2. Prior to evaluating the residue levels in the reported trials or in products of animal origin Member States shall examine the following information: — data on the proposed good agricultural practice, including data on application as provided for in the Annex to Regulation (EU) No 284/2013 and proposed pre-harvest intervals for envisaged uses, or withholding periods or storage periods, in the case of post-harvest uses, — nature of the preparation, — analytical methods and the residue definition.

1.4.2.3. On the basis of suitable statistical models Member States shall evaluate the residue levels observed in the reported trials. This evaluation shall be made for each proposed use and shall take into consideration: (i) the proposed conditions of use of the plant protection product; (ii) the specific information on residues in or on treated plants, plant products, food and feed as provided for in the Annex to Regulation (EU) No 284/2013 and the distribution of residues between edible and non-edible parts; (iii) the specific information on residues in or on treated plants, plant products, food and feed as provided for in the Annex to Regulation (EU) No 283/2013 and the results of the evaluation thereof; (iv) the realistic possibilities of extrapolating data from one crop to another.

1.4.2.4. Member States shall evaluate the residue levels observed in products of animal origin, taking into consideration the information provided for in Section 8 of Part A of the Annex to Regulation (EU) No 284/2013 and residues resulting from other uses.

1.4.2.5. Member States shall estimate the potential exposure of consumers through diet and, where relevant, other ways of exposure, using a suitable calculation model. This evaluation shall take account, where relevant, of other sources of information such as other authorised uses of plant protection products containing the same active substance or which give rise to the same residues.

1.4.2.6. Member States shall, where relevant, estimate the exposure of animals, taking into account the residue levels observed in treated plants or plant products intended to be fed to animals.

1.5. Influence on the environment

1.5.1. Fate and distribution in the environment In the evaluation of the fate and distribution of the plant protection product in the environment, Member States shall have regard to all aspects of the environment, including biota, and in particular to the following:

1.5.1.1. Member States shall evaluate the possibility of the plant protection product reaching the soil under the proposed conditions of use; if this possibility exists they shall estimate the rate and the route of degradation in the soil, the mobility in the soil and the change in the total concentration (extractable and non-extractable ( 5 ) ) of the active substance and of relevant metabolites, degradation and reaction products that could be expected in the soil in the area of envisaged use after use of the plant protection product in accordance with the proposed conditions of use. This evaluation shall take into consideration the following information: (i) the specific information on fate and behaviour in soil as provided for in the Annex to Regulation (EU) No 283/2013 and the results of the evaluation thereof; (ii) other relevant information on the active substance such as: — molecular weight, — solubility in water, — octanol/water partition coefficient, — vapour pressure, — volatilisation rate, — dissociation constant, — photodegradation rate and identity of breakdown products, — hydrolysis rate in relation to pH and identity of breakdown products. (iii) all information on the plant protection product as provided for in the Annex to Regulation (EU) No 284/2013, including the information on distribution and dissipation in soil; (iv) where relevant, other authorised uses of plant protection products in the area of proposed use containing the same active substance or which give rise to the same residues.

1.5.1.2. Member States shall evaluate the possibility of the plant protection product reaching the groundwater under the proposed conditions of use; if this possibility exists, they shall estimate, using a suitable calculation model validated at EU level, the concentration of the active substance and of relevant metabolites, degradation and reaction products that could be expected in the groundwater in the area of envisaged use after use of the plant protection product in accordance with the proposed conditions of use. As long as there is no validated EU calculation model, Member States shall base their evaluation especially on the results of mobility and persistence in soil studies as provided for in the Annex to Regulation (EU) No 283/2013 and to Regulation (EU) No 284/2013. This evaluation shall also take into consideration the following information: (i) the specific information on fate and behaviour in soil and water as provided for in the Annex to Regulation (EU) No 283/2013 and the results of the evaluation thereof; (ii) other relevant information on the active substance such as: — molecular weight, — solubility in water, — octanol/water partition coefficient, — vapour pressure, — volatilisation rate, — hydrolysis rate in relation to pH and identity of breakdown products, — dissociation constant; (iii) all information on the plant protection product as provided for in the Annex to Regulation (EU) No 284/2013, including the information on distribution and dissipation in soil and water; (iv) where relevant, other authorised uses of plant protection products in the area of envisaged use containing the same active substance or which give rise to the same residues; (v) where relevant, data on dissipation including transformation and sorption in the saturated zone; (vi) where relevant, data on the procedures for drinking water abstraction and treatment in the area of envisaged use; (vii) where relevant, monitoring data on the presence or absence of the active substance and relevant metabolites, degradation or reaction products in groundwater as a result of previous use of plant protection products containing the same active substance or which give rise to the same residues; such monitoring data shall be interpreted in a consistent scientific way.

1.5.1.3. Member States shall evaluate the possibility of the plant protection product reaching surface water under the proposed conditions of use; if this possibility exists they shall estimate, using a suitable calculation model validated at EU level, the short-term and long-term predicted concentration of the active substance and of metabolites, degradation and reaction products that could be expected in the surface water in the area of envisaged use after use of the plant protection product in accordance with the proposed conditions of use. If there is no validated EU calculation model, Member States shall base their evaluation especially on the results of mobility and persistence in soil studies and the information on run-off and drift as provided for in the Annex to Regulation (EU) No 283/2013 and to Regulation (EU) No 284/2013. This evaluation shall also take into consideration the following information: (i) the specific information on fate and behaviour in soil and water as provided for in the Annex to Regulation (EU) No 283/2013 and the results of the evaluation thereof; (ii) other relevant information on the active substance such as: — molecular weight, — solubility in water, — octanol/water partition coefficient, — vapour pressure, — volatilisation rate, — hydrolysis rate in relation to pH and identity of breakdown products, — dissociation constant; (iii) all relevant information on the plant protection product as provided for in the Annex to Regulation (EU) No 284/2013, including the information on distribution and dissipation in soil and water; (iv) possible routes of exposure: — drift, — run-off, — overspray, — discharge via drains, — leaching, — deposit from the atmosphere; (v) where relevant, other authorised uses of plant protection products in the area of envisaged use containing the same active substance or which give rise to the same residues; (vi) where relevant, data on the procedures for drinking water abstraction and treatment in the area of envisaged use.

1.5.1.4. Member States shall evaluate the possibility of the plant protection product being dissipated in the air under the proposed conditions of use; if this possibility exists they shall make the best possible estimation, using where appropriate a suitable, validated calculation model, of the concentration of the active substance and of relevant metabolites, degradation and reaction products that could be expected in the air after use of the plant protection product in accordance with the proposed conditions of use. This evaluation shall take into consideration the following information: (i) the specific information on fate and behaviour in soil, water and air as provided for in the Annex to Regulation (EU) No 283/2013 and the results of the evaluation thereof; (ii) other relevant information on the active substance such as: — vapour pressure, — solubility in water, — hydrolysis rate in relation to pH and identity of breakdown products, — photochemical degradation in water and air and identity of breakdown products, — octanol/water partition coefficient; (iii) all relevant information on the plant protection product as provided for in the Annex to Regulation (EU) No 284/2013, including the information on distribution and dissipation in air.

1.5.1.5. Member States shall evaluate the procedures for destruction or decontamination of the plant protection product and its packaging.

1.5.2. Impact on non-target species When calculating toxicity/exposure ratios Member States shall take into consideration toxicity to the most sensitive relevant organism used in the tests.

1.5.2.1. Member States shall evaluate the possibility of exposure of birds and other terrestrial vertebrates to the plant protection product under the proposed conditions of use; if this possibility exists they shall evaluate the extent of the short-term and long-term risk to be expected for these organisms, including their reproduction, after use of the plant protection product in accordance with the proposed conditions of use. (a) This evaluation shall take into consideration the following information: (i) the specific information relating to toxicological studies on mammals and to the effects on birds and other non-target terrestrial vertebrates, including effects on reproduction, and other relevant information concerning the active substance as provided for in the Annex to Regulation (EU) No 283/2013 and the results of the evaluation thereof; (ii) all relevant information on the plant protection product as provided for in the Annex to Regulation (EU) No 284/2013, including the information on effects on birds and other non-target terrestrial vertebrates; (iii) where relevant, other authorised uses of plant protection products in the area of envisaged use containing the same active substance or which give rise to the same residues. (b) This evaluation shall include: (i) the fate and distribution, including persistence and bioconcentration, of the active substance and of relevant metabolites, breakdown and reaction products in the various parts of the environment after application of the plant protection product; (ii) the estimated exposure of the species likely to be exposed at the time of application or during the period that residues are present, taking into account all relevant routes of exposure such as ingestion of the formulated product or treated food, predation on invertebrates, feeding on vertebrate prey, contact by overspraying or with treated vegetation; (iii) a calculation of the acute, short-term and, where necessary, long-term toxicity/exposure ratio. The toxicity/exposure ratios are defined as respectively the quotient of LD50, LC50 or non-observable effects of concentration (NOEC) expressed on an active substance basis and the estimated exposure expressed in mg/kg body weight.

1.5.2.2. Member States shall evaluate the possibility of exposure of aquatic organisms to the plant protection product under the proposed conditions of use; if this possibility exists they shall evaluate the degree of short-term and long-term risk to be expected for aquatic organisms after use of the plant protection product in accordance with the proposed conditions of use. (a) This evaluation shall take into consideration the following information: (i) the specific information relating to the effects on aquatic organisms as provided for in the Annex to Regulation (EU) No 283/2013 and the results of the evaluation thereof; (ii) other relevant information on the active substance such as: — solubility in water, — octanol/water partition coefficient, — vapour pressure, — volatilisation rate, — KOC, — biodegradation in aquatic systems and in particular the ready biodegradability, — photodegradation rate and identity of breakdown products, — hydrolysis rate in relation to pH and identity of breakdown products. (iii) all relevant information on the plant protection product as provided for in the Annex to Regulation (EU) No 284/2013 and in particular the effects on aquatic organisms; (iv) where relevant, other authorised uses of plant protection products in the area of envisaged use, containing the same active substance or which give rise to the same residues. (b) This evaluation shall include: (i) the fate and distribution of residues of the active substance and of relevant metabolites, breakdown and reaction products in water, sediment or fish; (ii) a calculation of the acute toxicity/exposure ratio for fish and Daphnia. This ratio is defined as the quotient of respectively acute LC50 or EC50 and the predicted short-term environmental concentration; (iii) a calculation of the algal growth inhibition/exposure ratio for algae. This ratio is defined as the quotient of the EC50 and the predicted short-term environmental concentration; (iv) a calculation of the long-term toxicity/exposure ratio for fish and Daphnia. The long-term toxicity/exposure ratio is defined as the quotient of the NOEC and the predicted long-term environmental concentration; (v) where relevant, the bioconcentration in fish and possible exposure of predators of fish, including humans; (vi) if the plant protection product is to be applied directly to surface water, the effect on the change of surface water quality, such as pH or dissolved oxygen content.

1.5.2.3. Member States shall evaluate the possibility of exposure of honeybees to the plant protection product under the proposed conditions of use; if this possibility exists they shall evaluate the short-term and long-term risk to be expected for honeybees after use of the plant protection product in accordance with the proposed conditions of use. (a) This evaluation shall take into consideration the following information: (i) the specific information on toxicity to honeybees as provided for in the Annex to Regulation (EU) No 283/2013 and the results of the evaluation thereof; (ii) other relevant information on the active substance such as: — solubility in water, — octanol/water partition coefficient, — vapour pressure, — photodegradation rate and identity of breakdown products, — mode of action (e. g. insect growth regulating activity); (iii) all relevant information on the plant protection product as provided for in the Annex to Regulation (EU) No 284/2013, including the toxicity to honeybees; (iv) where relevant, other authorised uses of plant protection products in the area of envisaged use, containing the same active substance or which give rise to the same residues. (b) This evaluation shall include: (i) the ratio between the maximum application rate expressed in grams of active substance per hectare and the contact and oral LD50 expressed in μg of active substance per bee (hazard quotients) and where necessary the persistence of residues on or, where relevant, in the treated plants; (ii) where relevant, the effects on honeybee larvae, honeybee behaviour, colony survival and development after use of the plant protection product in accordance with the proposed conditions of use.

1.5.2.4. Member States shall evaluate the possibility of exposure of beneficial arthropods other than honeybees to the plant protection product under the proposed conditions of use; if this possibility exists they shall assess the lethal and sublethal effects on these organisms to be expected and the reduction in their activity after use of the plant protection product in accordance with the proposed conditions of use. This evaluation shall take into consideration the following information: (i) the specific information on toxicity to honeybees and other beneficial arthropods as provided for in the Annex to Regulation (EU) No 283/2013 and the results of the evaluation thereof; (ii) other relevant information on the active substance such as: — solubility in water, — octanol/water partition coefficient, — vapour pressure, — photodegradation rate and identity of breakdown products, — mode of action (e. g. insect growth regulating activity); (iii) all relevant information on the plant protection product as provided for in the Annex to Regulation (EU) No 284/2013 such as: — effects on beneficial arthropods other than bees, — toxicity to honeybees, — available data from biological primary screening, — maximum application rate, — maximum number and timetable of applications; (iv) where relevant, other authorised uses of plant protection products in the area of envisaged use, containing the same active substance or which give rise to the same residues.

1.5.2.5. Member States shall evaluate the possibility of exposure of earthworms and other non-target soil macro-organisms to the plant protection product under the proposed conditions of use; if this possibility exists they shall evaluate the degree of short-term and long-term risk to be expected to these organisms after use of the plant protection product in accordance with the proposed conditions of use. (a) This evaluation shall take into consideration the following information: (i) the specific information relating to the toxicity of the active substance to earthworms and to other non-target soil macro-organisms as provided for in the Annex to Regulation (EU) No 283/2013 and the results of the evaluation thereof; (ii) other relevant information on the active substance such as: — solubility in water, — octanol/water partition coefficient, — Kd for adsorption, — vapour pressure, — hydrolysis rate in relation to pH and identity of breakdown products, — photodegradation rate and identity of breakdown products, — DT50 and DT90 for degradation in the soil. (iii) all relevant information on the plant protection product as provided for in the Annex to Regulation (EU) No 284/2013, including the effects on earthworms and other non-target soil macro-organisms; (iv) where relevant, other authorised uses of plant protection products in the area of envisaged use, containing the same active substance or which give rise to the same residues. (b) This evaluation shall include: (i) the lethal and sublethal effects; (ii) the predicted initial and long-term environmental concentration; (iii) a calculation of the acute toxicity/exposure ratio (defined as the quotient of LC50 and predicted initial environmental concentration) and of the long-term toxicity/exposure ratio (defined as the quotient of the NOEC and predicted long-term environmental concentration); (iv) where relevant, the bioconcentration and persistence of residues in earthworms.

1.5.2.6. Member States shall, where the evaluation carried out under point 1.5.1.1 does not exclude the possibility of the plant protection product reaching the soil under the proposed conditions of use, evaluate the impact on microbial activity such as the impact on nitrogen and carbon mineralisation processes in the soil after use of the plant protection product in accordance with the proposed conditions of use. This evaluation shall take into consideration the following information: (i) all relevant information on the active substance, including the specific information relating to the effects of non-target soil micro-organisms as provided for in the Annex to Regulation (EU) No 283/2013 and the results of the evaluation thereof; (ii) all relevant information on the plant protection product as provided for in the Annex to Regulation (EU) No 284/2013, including the effects on non-target soil micro-organisms; (iii) where relevant, other authorised uses of plant protection products in the area of proposed use, containing the same active substance or which give rise to the same residues; (iv) all available information from biological primary screening.

1.6. Analytical methods

Member States shall evaluate the analytical methods proposed for post-registration control and monitoring purposes, to determine:

1.6.1. for formulation analysis: the nature and quantity of the active substance(s) in the plant protection product and, where appropriate, any toxicologically, ecotoxicologically or environmentally significant impurities and co-formulants. This evaluation shall take into consideration the following information: (i) the data on analytical methods as provided for in the Annex to Regulation (EU) No 283/2013 and the results of the evaluation thereof; (ii) the data on analytical methods as provided for in the Annex to Regulation (EU) No 284/2013 and in particular: — the specificity and linearity of the proposed methods, — the importance of interferences, — the precision of the proposed methods (intralaboratory repeatability and interlaboratory reproducibility); (iii) the limit of detection and determination of the proposed methods for impurities.

1.6.2. for residue analysis: the residues of the active substance, metabolites, breakdown or reaction products resulting from authorised uses of the plant protection product and which are of toxicological, ecotoxicological or environmental significance. This evaluation shall take into consideration the following information: (i) the data on analytical methods as provided for in the Annex to Regulation (EU) No 283/2013 and the results of the evaluation thereof; (ii) the data on analytical methods as provided for in the Annex to Regulation (EU) No 284/2013 and in particular: — the specificity of the proposed methods, — the precision of the proposed methods (intralaboratory repeatability and interlaboratory reproducibility), — the recovery rate of the proposed methods at appropriate concentrations; (iii) the limit of detection of the proposed methods; (iv) the limit of determination of the proposed methods.

1.7. Physical and chemical properties

1.7.1. Member States shall evaluate the actual active substance content of the plant protection product and its stability during storage.

1.7.2. Member States shall evaluate the physical and chemical properties of the plant protection product and in particular: — where a suitable FAO (Food and Agriculture Organisation of the United Nations) specification exists, the physical and chemical properties addressed in that specification, — where no suitable FAO specification exists, all the relevant physical and chemical properties for the formulation as referred to in the ‘Manual on development and use of FAO and WHO specifications for pesticides’. This evaluation shall take into consideration the following information: (i) the data on the physical and chemical properties of the active substance as provided for in the Annex to Regulation (EU) No 283/2013 and the results of the evaluation thereof; (ii) the data on the physical and chemical properties of the plant protection product as provided for in the Annex to Regulation (EU) No 284/2013.

1.7.3. Where proposed label claims include requirements or recommendations for use of the plant protection product with other plant protection products or adjuvants as a tank mix, the physical and chemical compatibility of the products in the mixture must be evaluated.

2. DECISION-MAKING

These principles shall apply without prejudice to the general principles referred to in Section 3 of the general introduction.

2.1. Efficacy

2.1.1. Where the proposed uses include recommendations for the control of or protection against organisms which are not considered to be harmful on the basis of experience acquired or scientific evidence under normal agricultural, plant health and environmental (including climatic) conditions in the areas of proposed use or where the other intended effects are not considered to be beneficial under those conditions, no authorisation shall be granted for those uses.

2.1.2. The level, consistency and duration of control or protection or other intended effects must be similar to those resulting from the use of suitable reference products. If no suitable reference product exists, the plant protection product must be shown to give a defined benefit in terms of the level, consistency and duration of control or protection or other intended effects under the agricultural, plant health and environmental (including climatic) conditions in the area of proposed use.

2.1.3. Where relevant, yield response when the product is used and reduction of loss in storage must be quantitatively and/or qualitatively similar to those resulting from the use of suitable reference products. If no suitable reference product exists, the plant protection product must be shown to give a consistent and defined quantitative and/or qualitative benefit in terms of yield response and reduction of loss in storage under the agricultural, plant health and environmental (including climatic) conditions in the area of proposed use.

2.1.4. Conclusions as to the performance of the preparation must be valid for all areas of the Member State in which it is to be authorised, and must hold for all conditions under which its use is proposed, except where the proposed label specifies that the preparation is intended for use in certain specified circumstances (e.g. light infestations, particular soil types or particular growing conditions).

2.1.5. Where proposed label claims include requirements for use of the preparation with other specified plant protection products or adjuvants as a tank mix, the mixture must achieve the desired effect and comply with the principles referred to in points 2.1.1 to 2.1.4. Where proposed label claims include recommendations for use of the preparation with specified plant protection products or adjuvants as a tank mix, Member States shall not accept the recommendations unless they are justified.

2.2. Absence of unacceptable effects on plants or plant products

2.2.1. There must be no relevant phytotoxic effects on treated plants or plant products except where the proposed label indicates appropriate limitations of use.

2.2.2. There must be no reduction of yield at harvest due to phytotoxic effects below that which could be obtained without the use of the plant protection product, unless this reduction is compensated for by other advantages such as an enhancement of the quality of the treated plants or plant products.

2.2.3. There must be no unacceptable adverse effects on the quality of treated plants or plant products, except in the case of adverse effects on processing where proposed label claims specify that the preparation must not be applied to crops to be used for processing purposes.

2.2.4. There must be no unacceptable adverse effects on treated plants or plant products used for propagation or reproduction, such as effects on viability, germination, sprouting, rooting and establishment, except where proposed label claims specify that the preparation should not be applied to plants or plant products to be used for propagation or reproduction.

2.2.5. There must be no unacceptable impact on succeeding crops, except where proposed label claims specify that particular crops, which would be affected, must not be grown following the treated crop.

2.2.6. There must be no unacceptable impact on adjacent crops, except where proposed label claims specify that the preparation should not be applied when particular sensitive adjacent crops are present.

2.2.7. Where proposed label claims include requirements for use of the preparation with other plant protection products or adjuvants, as a tank mix, the mixture must comply with the principles referred to in points 2.2.1 to 2.2.6.

2.2.8. The proposed instructions for cleaning the application equipment must be both practical and effective so that they can be applied with ease to ensure the removal of residual traces of the plant protection product which could subsequently cause damage.

2.3. Impact on vertebrates to be controlled

An authorisation for a plant protection product intended to eliminate vertebrates shall be granted only when:

— death is synchronous with the extinction of consciousness, or

— death occurs immediately, or

— vital functions are reduced gradually without signs of obvious suffering.

For repellent products, the intended effect shall be obtained without unnecessary suffering and pain for the target animals.

2.4. Impact on human or animal health

2.4.1. Impact on human or animal health arising from the plant protection product

2.4.1.1. No authorisation shall be granted if the extent of operator exposure in handling and using the plant protection product under the proposed conditions of use, including dose and application method, exceeds the AOEL. Moreover, the conditions of the authorisation shall be in compliance with the limit value established for the active substance and/or toxicologically relevant compound(s) of the product in accordance with Council Directive 98/24/EC (6) and in accordance with Directive 2004/37/EC of the European Parliament and of the Council (7).

2.4.1.2. Where the proposed conditions of use require use of items of protective clothing and equipment, no authorisation shall be granted unless those items are effective and in accordance with the relevant EU provisions and are readily obtainable by the user and unless it is feasible to use them under the circumstances of use of the plant protection product, taking into account climatic conditions in particular.

2.4.1.3. Plant protection products which because of particular properties or if mishandled or misused could lead to a high degree of risk must be subject to particular restrictions such as restrictions on the size of packaging, formulation type, distribution, use or manner of use. Moreover, those plant protection products may not be authorised for use by non-professional users which are classified as: (i) acute toxicity category 1 and 2 for any route of uptake, provided the ATE (acute toxicity estimate) of the product does not exceed 25 mg/kg bw for the oral route of uptake or 0,25 mg/l/4h for the inhalation of dust, mist or fume; (ii) STOT (single exposure), category 1 (oral), provided their classification is due to the presence of classified substances showing significant non-lethal toxic effects at guidance values below 25 mg/kg bw; (iii) STOT (single exposure), category 1 (dermal), provided their classification is due to the presence of classified substances showing significant non-lethal toxic effects at guidance values below 50 mg/kg bw; (iv) STOT (single exposure), category 1 (inhalation of gas/vapour), provided their classification is due to the presence of classified substances showing significant non-lethal toxic effects at guidance values below 0,5 mg/l/4h; (v) STOT (single exposure), category 1 (inhalation of dust/mist/fume), provided their classification is due to the presence of classified substances showing significant non-lethal toxic effects at guidance values below 0,25 mg/l/4h.

2.4.1.4. Waiting and re-entry safety periods or other precautions must be such that the exposure of bystanders or workers exposed after the application of the plant protection product does not exceed the AOEL levels established for the active substance or toxicologically relevant compound(s) in the plant protection product nor any limit values established for those compounds in accordance with the EU provisions referred to in point 2.4.1.1.

2.4.1.5. Waiting and re-entry safety periods or other precautions must be established in such a way that no adverse impact on animals occurs.

2.4.1.6. Waiting and re-entry periods or other precautions to ensure that the AOEL levels and limit values are respected must be realistic; if necessary special precautionary measures must be prescribed.

2.4.2. Impact on human or animal health arising from residues

2.4.2.1. Authorisations must ensure that residues occurring reflect the minimum quantities of the plant protection product necessary to achieve adequate control corresponding to good agricultural practice, applied in such a manner (including pre-harvest intervals or withholding periods or storage periods) that the residues at harvest, slaughter or after storage, as appropriate, are reduced to a minimum.

2.4.2.2. Where the new circumstances under which the plant protection product is to be used do not correspond to those under which a MRL (maximum residue limit) was established previously, Member States shall not grant an authorisation for the plant protection product unless the applicant can provide evidence that its recommended use shall not exceed the MRL established under Regulation (EC) No 396/2005 of the European Parliament and of the Council ( 8 )

2.4.2.3. Where a MRL exists Member States shall not grant an authorisation for the plant protection product unless the applicant can provide evidence that its recommended use shall not exceed that MRL, or unless a new MRL has been established under Regulation (EC) No 396/2005.

2.4.2.4. In the cases referred to in points 2.4.2.2, each application for an authorisation must be accompanied by a risk assessment taking into account worst-case potential exposure of consumers in the Member State concerned on the basis of good agricultural practice. Taking into account all registered uses, the proposed use shall not be authorised if the best possible estimate of dietary exposure exceeds the ADI.

2.4.2.5. Where the nature of residues is affected during processing, a separate risk assessment may need to be carried out under the conditions provided for in point 2.4.2.4.

2.4.2.6. Where the treated plants or plant products are intended to be fed to animals, residues occurring shall not have an adverse effect on animal health.

2.5. Influence on the environment

2.5.1. Fate and distribution in the environment

2.5.1.1. No authorisation shall be granted if the active substance and, where they are of significance from the toxicological, ecotoxicological or environmental point of view, metabolites and breakdown or reaction products, after use of the plant protection product under the proposed conditions of use: — during tests in the field, persist in soil for more than 1 year (i.e. DT90 > 1 year and DT50 > 3 months), or — during laboratory tests, form non-extractable residues in amounts exceeding 70 % of the initial dose after 100 days with a mineralisation rate of less than 5 % in 100 days, unless it is scientifically demonstrated that under field conditions there is no accumulation in soil at such levels that unacceptable residues in succeeding crops occur and/or that unacceptable phytotoxic effects on succeeding crops occur and/or that there is an unacceptable impact on the environment, in accordance with the relevant requirements provided for in points 2.5.1.2, 2.5.1.3, 2.5.1.4 and 2.5.2.

2.5.1.2. No authorisation shall be granted if the concentration of the active substance or of relevant metabolites, degradation or reaction products in groundwater, may be expected to exceed, as a result of use of the plant protection product under the proposed conditions of use, the lower of the following limit values: (i) the maximum permissible concentration laid down by Council Directive 98/83/EC (9); or (ii) the maximum concentration laid down when approving the active substance in accordance with Regulation (EC) No 1107/2009, on the basis of appropriate data, in particular toxicological data, or, where that concentration has not been laid down, the concentration corresponding to one tenth of the ADI laid down when the active substance was approved in accordance with Regulation (EC) No 1107/2009, unless it is scientifically demonstrated that under relevant field conditions the lower concentration is not exceeded.

2.5.1.3. No authorisation shall be granted if the concentration of the active substance or of relevant metabolites, breakdown or reaction products to be expected after use of the plant protection product under the proposed conditions of use in surface water: — exceeds, where the surface water in or from the area of envisaged use is intended for the abstraction of drinking water, concentrations above which compliance with drinking water quality established in accordance with Directive 2000/60/EC of the European Parliament and of the Council (10) is compromised, or — has an impact deemed unacceptable on non-target species, including animals, in accordance with the relevant requirements provided for in point 2.5.2. The proposed instructions for use of the plant protection product, including procedures for cleaning application equipment, must be such that the likelihood of accidental contamination of surface water is reduced to a minimum.

2.5.1.4. No authorisation shall be granted if the airborne concentration of the active substance under the proposed conditions of use is such that either the AOEL or the limit values for operators, bystanders or workers as referred to in point 2.4.1 are exceeded.

2.5.2. Impact on non-target species

2.5.2.1. Where there is a possibility of birds and other non-target terrestrial vertebrates being exposed, no authorisation shall be granted if: — the acute and short-term toxicity/exposure ratio for birds and other non-target terrestrial vertebrates is less than 10 on the basis of LD50 or the long-term toxicity/exposure ratio is less than 5, unless it is clearly established through an appropriate risk assessment that under field conditions no unacceptable impact occurs after use of the plant protection product in accordance with the proposed conditions of use, — the bioconcentration factor (BCF, related to fat tissue) is greater than 1, unless it is clearly established through an appropriate risk assessment that under field conditions no unacceptable effects occur — directly or indirectly — after use of the plant protection product in accordance with the proposed conditions of use.

2.5.2.2. Where there is a possibility of aquatic organisms being exposed, no authorisation shall be granted if: — the toxicity/exposure ratio for fish and Daphnia is less than 100 for acute exposure and less than 10 for long-term exposure, or — the algal growth inhibition/exposure ratio is less than 10, or — the maximum bioconcentration factor (BCF) is greater than 1 000 for plant protection products containing active substances which are readily biodegradable or greater than 100 for those which are not readily biodegradable, unless it is clearly established through an appropriate risk assessment that under field conditions no unacceptable impact on the viability of exposed species (predators) occurs — directly or indirectly — after use of the plant protection product in accordance with the proposed conditions of use.

2.5.2.3. Where there is a possibility of honeybees being exposed, no authorisation shall be granted if the hazard quotients for oral or contact exposure of honeybees are greater than 50, unless it is clearly established through an appropriate risk assessment that under field conditions there are no unacceptable effects on honeybee larvae, honeybee behaviour, or colony survival and development after use of the plant protection product in accordance with the proposed conditions of use.

2.5.2.4. Where there is a possibility of beneficial arthropods other than honeybees being exposed, no authorisation shall be granted if more than 30 % of the test organisms are affected in lethal or sublethal laboratory tests conducted at the maximum proposed application rate, unless it is clearly established through an appropriate risk assessment that under field conditions there is no unacceptable impact on those organisms after use of the plant protection product in accordance with the proposed conditions of use. Any claims for selectivity and proposals for use in integrated pest management systems shall be substantiated by appropriate data.

2.5.2.5. Where there is a possibility of earthworms being exposed, no authorisation shall be granted if the acute toxicity/exposure ratio for earthworms is less than 10 or the long-term toxicity/exposure ratio is less than 5, unless it is clearly established through an appropriate risk assessment that under field conditions earthworm populations are not at risk after use of the plant protection product in accordance with the proposed conditions of use.

2.5.2.6. Where there is a possibility of non-target soil micro-organisms being exposed, no authorisation shall be granted if the nitrogen or carbon mineralisation processes in laboratory studies are affected by more than 25 % after 100 days, unless it is clearly established through an appropriate risk assessment that under field conditions there is no unacceptable impact on microbial activity after use of the plant protection product in accordance with the proposed conditions of use, taking account of the ability of micro-organisms to multiply.

2.6. Analytical methods

The methods proposed must reflect the state of the art. The following criteria must be met in order to permit validation of the analytical methods proposed for post-registration control and monitoring purposes:

2.6.1. for formulation analysis: the method must be able to determine and to identify the active substance(s) and where appropriate any toxicologically, ecotoxicologically or environmentally significant impurities and co-formulants;

2.6.2. for residue analysis: (i) the method must be able to determine and confirm residues of toxicological, ecotoxicological or environmental significance; (ii) the mean recovery rates should be between 70 % and 110 % with a relative standard deviation of ≤ 20 %; (iii) the repeatability must be less than the following values for residues in foodstuffs: Residue level mg/kg Difference mg/kg Difference in % 0,01 0,005 50 0,1 0,025 25 1 0,125 12,5 >1 12,5 Intermediate values shall be determined by interpolation from a log-log graph; (iv) the reproducibility must be less than the following values for residues in foodstuffs: Residue level mg/kg Difference mg/kg Difference in % 0,01 0,01 100 0,1 0,05 50 1 0,25 25 >1 25 Intermediate values are determined by interpolation from a log-log graph; (v) in the case of residue analysis in treated plants, plant products, foodstuffs, feedingstuffs or products of animal origin, except where the MRL or the proposed MRL is at the limit of determination, the sensitivity of the methods proposed must satisfy the following criteria: Limit of determination in relation to the proposed provisional or EU MRL: MRL (mg/kg) limit of determination (mg/kg) > 0,5 0,1 0,5 – 0,05 0,1 – 0,02 < 0,05 MRL × 0,5

2.7. Physical and chemical properties

2.7.1 Where an appropriate FAO specification exists, that specification must be met.

2.7.2. Where no appropriate FAO specification exists, the physical and chemical properties of the product must meet the following requirements (a) Chemical properties: Throughout the shelf-life period, the difference between the stated and the actual content of the active substance in the plant protection product must not exceed the following values: Declared content in g/kg or g/l at 20 °C Tolerance up to 25 ±15 % homogeneous formulation ±25 % non-homogeneous formulation more than 25 up to 100 ±10 % more than 100 up to 250 ±6 % more than 250 up to 500 ±5 % more than 500 ±25 g/kg or ±25 g/l (b) Physical properties: The plant protection product must fulfil the physical criteria (including storage stability) specified for the relevant formulation type in the ‘Manual on the development and use of FAO and WHO specifications for plant protection products’.

2.7.3. Where the proposed label claims include requirements or recommendations for use of the preparation with other plant protection products or adjuvants as a tank mix and/or where the proposed label includes indications on the compatibility of the preparation with other plant protection products as a tank mix, those products or adjuvants must be physically and chemically compatible in the tank mix.

PART B

UNIFORM PRINCIPLES FOR EVALUATION AND AUTHORISATION OF PLANT PROTECTION PRODUCTS CONTAINING AN ACTIVE SUBSTANCE THAT IS A MICRO-ORGANISM

Definitions

For the purposes of Part B, in addition to general introduction, the following definitions apply:

(1) ‘strain’ means a genetic variant of an organism in its taxonomic level (species) that is made up of the descendants of a single isolation in pure culture from the original matrix (e.g. the environment) and usually is made up of a succession of cultures ultimately derived from an initial single colony;

(2) ‘Microbial Pest Control Agent as manufactured’ (‘MPCA as manufactured’) means the outcome of the manufacturing process of the micro-organism(s) intended to be used as active substance in plant protection products, consisting of the micro-organism(s) and any additives, metabolites (including metabolites of concern), chemical impurities (including relevant impurities), contaminating micro-organisms (including relevant contaminating micro-organisms) and the spent medium/rest fraction resulting from the manufacturing process or, in case of a continuous manufacturing processes where a strict separation between the manufacturing of the micro-organism(s) and the production process of the plant protection product is not possible, a non-isolated intermediate;

(3) ‘relevant contaminating micro-organism’ means a pathogenic/infective micro-organism unintentionally present in the MPCA as manufactured;

(4) ‘spent medium/rest fraction’ means the fraction of the MPCA as manufactured consisting of remaining or transformed starting materials, and excluding the micro-organism(s) that is the active substance, metabolites of concern, additives, relevant contaminating micro-organisms, and relevant impurities;

(5) ‘starting material’ means substances used in the manufacturing process of the MPCA as manufactured as substrate and/or buffering agent;

(6) ‘ecological niche’ means an ecological function and actual physical spaces occupied by a particular species within the community or ecosystem;

(7) ‘host range’ means the range of different biological host-species that can be infected by a microbial species or strain;

(8) ‘infectivity’ means the ability of a micro-organism to cause an infection;

(9) ‘infection’ means the non-opportunistic introduction or entry of a micro-organism into a susceptible host, where the micro-organism is able to reproduce to form new infective units and persist in the host, whether or not it causes pathological effects or disease;

(10) ‘pathogenicity’ means the non-opportunistic ability of a micro-organism to inflict injury and damage to the host upon infection;

(11) ‘non-opportunistic’ means a condition under which a micro-organism exerts an infection or inflicts injury or damage when the host is not weakened by a predisposing factor (e.g. immune system impaired by an unrelated cause);

(12) ‘opportunistic infection’ means an infection occurring in a host weakened by a predisposing factor (e.g. immune system impaired by an unrelated cause);

(13) ‘virulence’ means the degree of pathogenicity that a pathogenic micro-organism is able to exert in the host;

(14) ‘metabolite of concern’ means a metabolite produced by the micro-organism under assessment, with known toxicity or known relevant antimicrobial activity, which is present in the MPCA as manufactured at levels that may present a risk to human health, animal health or the environment, and/or for which it cannot be adequately justified that in-situ production of the metabolite is not relevant for the risk assessment;

(15) ‘background level of a metabolite’ means a level of a metabolite that is likely to occur in relevant European environments (including also sources different than those of plant protection) and/or in food and feed (e.g. edible plant parts), when the micro-organisms are in conditions to grow, reproduce and to produce such metabolite in presence of a host or availability of carbon and nutrient sources, under consideration of high host densities and nutrients;

(16) ‘in-situ production’ means the production of a metabolite by the micro-organism after application of the plant protection product containing that micro-organism;

(17) ‘antibiosis’ means a relationship between two or more species in which one species is actively harmed (as by the production of toxins by the harming species);

(18) ‘antimicrobial resistance’ (‘AMR’) means the intrinsic or acquired ability of a micro-organism to multiply in the presence of an antimicrobial agent at concentrations which are relevant for therapeutic measures in human or veterinary medicine, making that substance therapeutically ineffective;

(19) ‘antimicrobial agent’ means any antibacterial, antiviral, antifungal, anthelmintic or antiprotozoal agent that is a substance of natural, semi-synthetic, or synthetic origin that at in vivo concentrations kills or inhibits the growth of micro-organisms by interacting with a specific target;

(20) ‘acquired antimicrobial resistance’ means a non-intrinsic and acquired novel resistance enabling a micro-organism to survive or multiply in the presence of an antimicrobial agent at concentrations higher than that which inhibits wild type strains of the same species;

(21) ‘intrinsic antimicrobial resistance’ means all inherent properties of a microbial species that limit the action of antimicrobial agents thereby allowing it to survive and multiply in presence of the antimicrobial agents at concentrations that are relevant for their therapeutic uses. Inherent properties of micro-organisms are considered not transferable and can include structural characteristics such as lack of drug targets, the impermeability of cellular envelopes, activity of multidrug efflux pumps, or metabolic enzymes. An antimicrobial resistance gene is considered intrinsic if it is located on a chromosome in the absence of mobile genetic element and shared by the majority of wild type strains of the same species;

(22) ‘relevant antimicrobial activity’ means the antimicrobial activity caused by relevant antimicrobial agents;

(23) ‘relevant antimicrobial agents’ means all antimicrobial agents important for therapeutic use in humans or animals, as described in the latest available versions at the time of submission of the dossier: — in a list adopted by means of Commission Regulation (EU) 2021/1760 (11) in accordance with Article 37(5) of Regulation (EU) 2019/6 of the European Parliament and of the Council (12), or — by the World Health Organisation (13) in the lists of Critically Important Antimicrobials, Highly Important Antimicrobials and Important Antimicrobials for Human Medicine.

1. EVALUATION

Member States shall consider during the evaluations that:

— micro-organisms are living organisms capable of replication that may be naturally present in high numbers in the environment, and the specific micro-organism under assessment may already be occurring in relevant European environments at a relevant taxonomic level,

— the biological properties and the mode of action of a micro-organism are the first and crucial step in the evaluation process, because they define which are the relevant aspects and elements on which the evaluation should focus, and also which aspects are not relevant for a robust informed decision making,

— extensive information on the micro-organism under assessment (at the relevant taxonomic level) may be available in the public domain (e.g. history of use, peer-reviewed scientific literature). Best use of this information shall be made. Where applicable, regulatory experimental studies may be needed to determine the specific properties of the micro-organism under evaluation.

Metabolism is inherent of all living organisms. If secondary metabolites that are known to be hazardous to humans or other non-target organisms have been identified during the assessment of the micro-organism, the evaluation of a plant protection product containing this micro-organism shall include an assessment of the risk due to exposures to such metabolites expected from the intended use.

Member States shall implement the following principles in the evaluation of the data and information submitted in support of applications, without prejudice to the general principles prescribed in Section 2 of the general introduction.

1.1. Identity and manufacturing information

An overall assessment is necessary for those data on the identity and manufacturing information required according to Section 1 of Part B of the Annex to Regulation (EU) No 283/2013 and Section 1 of Part B of the Annex to Regulation (EU) No 284/2013.

1.1.1. Identity of the micro-organism contained in the plant protection product Member States shall verify the identity of the micro-organism that is the active substance based on information provided under point 1.3 of Part B of the Annex to Regulation (EU) No 283/2013. Furthermore, Member States shall evaluate if the MPCA as manufactured used for manufacturing of the plant protection product complies with specification of the MPCA as manufactured characterised and quantified as required in point 1.4 of Part B of the Annex to Regulation (EU) No 283/2013 (e.g. in terms of content and identity of the micro-organism(s), metabolites of concern, additives, relevant contaminating micro-organisms, and relevant impurities).

1.1.2. Quality control of the production of the micro-organism contained in the plant protection product Member States shall evaluate the quality assurance criteria proposed for the production of the active substance. Process control, good manufacturing practice, operational practices, process flows, cleaning practices, microbial monitoring and hygiene conditions shall be present and ensure stable quality of the MPCA as manufactured.

1.1.3. Identity of the plant protection product Member States shall evaluate the detailed quantitative and qualitative information provided on the composition of the plant protection product as required in point 1.4 of Part B of the Annex to Regulation (EU) No 284/2013, e.g. micro-organism (active substance), metabolites of concern, relevant impurities, relevant contaminating micro-organisms, co-formulants, safeners and synergists.

1.1.4. Quality control of the plant protection product Member States shall evaluate the quality assurance criteria proposed, in particular whether strict maintenance of environmental conditions and quality control analysis during the manufacturing process have been assured by the producer, in order to ensure compliance with the limits for relevant contaminating micro-organisms, relevant impurities and metabolites of concern.

1.2. Biological, physical, chemical and technical properties

Member States shall carry out an overall assessment of the information on biological, physical, chemical, and technical properties of the plant protection product provided under Section 2 of Part B of the Annex to Regulation (EU) No 283/2013 and Section 2 of Part B of the Annex to Regulation (EU) No 284/2013.

1.2.1. Biological properties of the micro-organism in the plant protection product

1.2.1.1. Member States shall evaluate information on the origin, occurrence and history of use of the micro-organism contained the plant protection product, giving particular relevance to both the location from which the strain was isolated, and the geographical distribution of the micro-organism at the relevant highest taxonomic level in relevant European environments.

1.2.1.2. Member States shall evaluate information on the ecology and the life cycle of the micro-organism, taking also into consideration the population densities of the micro-organism in relation to host densities as provided for in point 2.3 of Part B of the Annex to Regulation (EU) No 283/2013. In particular, for bacteriophages, the lysogenic and lytic properties of the virus shall be evaluated.

1.2.1.3. Member States shall evaluate information on the mode of action on the target organisms for the plant protection product to identify potential risks and function of the active substance that is a micro-organism according to the proposed conditions of use. In particular, Member States shall evaluate the role of possible infectivity, pathogenicity, toxicity and relevant antimicrobial activity in the mode of action against the target organism. If applicable, factors that enhance the pathogenicity/virulence of a micro-organism and environmental factors affecting a pathogenic mode of action shall be described. Information on the mode of action can be a very valuable tool in identifying potential risks and purpose of the micro-organism in the plant protection product. Aspects to be considered in the evaluation are, for instance: (a) invertebrate pathogenicity; (b) parasitisation; (c) competition for the ecological niche (e.g. nutrients, habitats); (d) endophytic growth; (e) interference with the virulence of a pathogenic target organism; (f) induction of plant defence; (g) antibiosis.

1.2.1.4. Member States shall evaluate data provided on the host range of the micro-organism, taking into account any available information on the relationship of the micro-organism to known pathogens to humans, animals, plants and other non-target species, at the most appropriate taxonomic level.

1.2.1.5. Member States shall evaluate information on growth requirements, by defining limiting factors e.g. UV light, humidity, pH, temperatures and other relevant agro-environmental conditions influencing the growth of the micro-organism.

1.2.1.6. Member States shall evaluate the genetic stability of a micro-organism that is a non-virulent variant of a plant pathogen virus, taking into consideration the likelihood of the micro-organisms to regain virulence, and the risk that could be caused by this occurrence.

1.2.1.7. In order to determine whether the micro-organism produces metabolites of concern, Member States shall take into account the information on production, toxicity and exposure concerning metabolites as provided for in points 2.8, 6.1, 6.2, 5.5, 7.2 and 8.8 of Part B of the Annex to Regulation (EU) No 283/2013.

1.2.1.8. For bacteria, Member States shall evaluate information on phenotypical resistance to relevant antimicrobial agents. Member States shall evaluate, taking into consideration that resistance genes in bacteria can be horizontally transmitted, and that this may potentially interfere with the effectiveness of relevant antimicrobial agents, information on the presence and transferability of genes coding for resistance to such antimicrobial agents.

1.2.2. Physical, chemical and technical properties of the plant protection product

1.2.2.1. Member States shall evaluate shelf-life and storage stability of the plant protection product, taking into account the packaging, optimal (recommended) storage temperature, and light conditions. Possible changes in composition due to growth or decline of the micro-organism or of relevant contaminating micro-organisms, or the production of metabolites of concern during storage, etc., shall be considered.

1.2.2.2. Member States shall evaluate the physical and chemical properties of the plant protection product and the retention of these characteristics after storage and take into consideration, unless a suitable FAO specification exists, all relevant physical and chemical properties of the plant protection product.

1.2.2.3. Where the proposed label includes requirements or recommendations for use of the plant protection product in combination with other plant protection products or adjuvants as a tank mix, Member states shall evaluate whether the plant protection product is physically and chemically compatible with those other plant protection products or adjuvants in the tank mix.

1.3. Efficacy

Member States shall evaluate the efficacy of the plant protection product based on those data submitted in accordance with Section 6 of Part B of the Annex to Regulation (EU) No 284/2013.

1.3.1. Where the proposed use concerns the control of or protection against an organism, Member States shall evaluate if the target organism could be a danger to plant health under the agricultural and environmental (including climatic) conditions in the area of the proposed use.

1.3.2. Member States shall evaluate whether significant damage to plants or plant products or loss in yields could occur under the agricultural and environmental (including climatic) conditions in the area of proposed use, if the plant protection product was not used.

1.3.3. Member States shall evaluate the efficacy data provided for in Part B of the Annex to Regulation (EU) No 284/2013 for the plant protection product, having regard to the degree of control or the extent of the effect desired and to relevant experimental conditions such as: (a) the choice of the crop or cultivar; (b) the agricultural and environmental (including climatic) conditions (if necessary for a specific use such data/information shall also be given for the time before and after application); (c) the presence and density of the target organism; (d) the development stage of crop and target organism; (e) the application rate of the plant protection product; (f) if required on the label, the application rate of adjuvant to be added; (g) the frequency and timing of the applications; (h) the type of application equipment to be used; (i) the need for any special cleaning measures for the application equipment before and after use.

1.3.4. Member States shall evaluate the efficacy of the plant protection product under the range of agricultural, plant health and environmental (including climatic) conditions likely to be encountered in practice in the area of proposed use. The evaluation shall include the compatibility with integrated pest management. In particular, consideration shall be paid to: (a) the level, consistency and duration of the effect sought in relation to the proposed dose; (b) the comparison of the proposed dose with a suitable reference product or products, where they exist, and an untreated control; (c) where relevant, the effect on yield or reduction of loss in storage, in terms of quantity and/or quality, in comparison with a suitable reference product or products, where they exist, and an untreated control; (d) the risk of occurrence and development of resistance or cross-resistance in populations of target organism. Where no suitable reference product exists, Member States shall evaluate the efficacy of the plant protection product to determine whether there is a consistent and defined benefit under the agricultural, plant health and environmental (including climatic) conditions likely to be encountered in practice in the area of proposed use.

1.3.5. Member States shall evaluate possible occurrence of adverse effects and their degree, on the treated crop after use of the plant protection product in accordance with the proposed conditions of use in comparison, where relevant, with a suitable reference product or products, where they exist, and/or an untreated control. (a) This evaluation shall take into consideration the following information: (i) efficacy data; (ii) other relevant information on the plant protection product such as nature of the plant protection product, dose, method of application, number and timing of applications, incompatibility with other crop treatments; (iii) all relevant information on the micro-organism, including biological properties e.g. mode of action, survival, host range specificity. (b) This evaluation shall include: (i) the nature, frequency, level and duration of observed phytotoxic/phytopathogenic effects and the agricultural, plant health and environmental (including climatic) conditions that affect them; (ii) differences between main cultivars with regard to their sensitivity to phytotoxic/phytopathogenic effects; (iii) the part of the treated crop or plant products where phytotoxic/phytopathogenic effects are observed; (iv) adverse impact on the yield of the treated crop or plant products in terms of quantity and/or quality, and on transformation processes; (v) adverse impact on treated plants or plant products to be used for propagation, in terms of viability, germination, sprouting, rooting and establishment; (vi) where micro-organisms are disseminated, in particular for weed control, any adverse impact on adjacent crops.

1.3.6. Where the proposed label of the plant protection product includes recommendations or requirements for the use of the plant protection product with other plant protection products and/or adjuvants as a tank mix, Member States shall make the evaluations referred to in points 1.3.3 to 1.3.5 with regard to the information supplied for the tank mix, and shall evaluate the appropriateness of the mix and of its conditions of use.

1.3.7. Member States shall evaluate potential effects (e.g. antagonism, fungicidal effects) on the activity of the micro-organism after mixing or spraying in sequence (or employing other relevant types of applications) with other plant protection products in accordance with the instructions proposed by the applicant on the label.

1.3.8. Where the available data indicate that the micro-organism has adverse effects on plants, or that metabolites of concern that have adverse effects on plants can persist in soil, and/or persist in/on plants in significant quantities after use of the plant protection product in accordance with the proposed conditions of use, Member States shall evaluate the degree of adverse effects on succeeding crops, taking into consideration the relevant information provided for under point 6.6 of Part B of the Annex to Regulation (EU) No 284/2013.

1.3.9. Member States shall evaluate potential negative effects of the micro-organism on beneficial organisms, either deliberately released, or as part of other practices (e.g. conservation biological control), taking into consideration the relevant information provided for under point 6.7 of Part B of the Annex to Regulation (EU) No 284/2013.

1.3.10. Where the proposed use of a plant protection product is intended to have an effect on vertebrates, Member States shall evaluate the mechanism by which this effect is obtained and the observed effects on the behaviour and health of the target animals. When the intended effect is to kill the target animal they shall evaluate the time necessary to obtain the death of the animal and the conditions under which death occurs. This evaluation shall take into consideration the following information: (a) all relevant information as provided for under Part B of the Annex to Regulation (EU) No 283/2013 and the results of the evaluation thereof, including the toxicological studies; (b) all relevant information on the plant protection product as provided for under Part B of the Annex to Regulation (EU) No 284/2013, including toxicological studies and efficacy data.

1.3.11. If there is evidence of development of resistance of the target organism towards the plant protection product requiring a resistance management strategy, the Member State shall evaluate if the submitted resistance management strategy, required according to point 6.4 of Part B of the Annex to Regulation (EU) No 284/2013, addresses this adequately and sufficiently.

1.4. Identification/detection and quantification methods

Member States shall assess data on the identification/detection and quantification methods submitted in accordance with Section 4 of Part B of the Annex to Regulation (EU) No 283/2013 and Section 5 of Part B of the Annex to Regulation (EU) No 284/2013.

Member States shall evaluate the analytical methods proposed for control and monitoring purposes, of the micro-organism both in the plant protection product and, where relevant, in or on edible parts of treated crops. In addition, where relevant, the analytical methods relating to metabolites of concern and relevant impurities present in the plant protection product shall also be evaluated. Appropriate validation data shall be provided by the applicant as regards the pre-authorisation analytical methods and post-authorisation monitoring methods. Methods that are considered suitably validated for post-authorisation monitoring shall be clearly identified.

1.4.1. Analytical methods for the plant protection product The evaluation concerning analytical methods for the plant protection product shall take into consideration the relevant information provided for under point 4.1 of Part B of the Annex to Regulation (EU) No 283/2013 and under point 5.1 of Part B of the Annex to Regulation (EU) No 284/2013.

1.4.1.1. Analytical methods for micro-organisms Member States shall evaluate the methods proposed to identify and quantify the micro-organism, and especially methods that discriminate that micro-organism from closely related strains. These methods shall include the most appropriate molecular analytical and phenotypic methods, to allow unequivocal distinction between the micro-organism under assessment, and other strains belonging to the same species. Member States shall also evaluate the methods proposed to identify and quantify relevant contaminating micro-organisms.

1.4.1.2. Analytical methods for metabolites of concern, relevant impurities, additives, co-formulants, safeners and synergist Where applicable, Member States shall evaluate the analytical methods proposed to identify and quantify metabolites of concern identified according to point 2.8 of Part B of the Annex to Regulation (EU) No 283/2013, relevant impurities, co-formulants, safeners and synergists.

1.4.2. Analytical methods for the determination of residues and density of the micro-organism Member States shall take into consideration the relevant information provided for under point 4.2 of Part B of the Annex to Regulation (EU) No 283/2013 and under point 5.2 of Part B of the Annex to Regulation (EU) No 284/2013.

1.4.2.1. Density of the micro-organism Member States shall evaluate the methods proposed to identify and quantify the density of the micro-organism, where relevant, on and/or in crops, in foodstuffs and feeding stuffs, in animal and human body tissues and fluids, in relevant environmental compartment.

1.4.2.2. Residues of metabolites of concern Member States shall evaluate the analytical methods proposed to identify and quantify residues of metabolites of concern, where relevant, on and/or in crops, in foodstuffs and feeding stuffs, in animal and human body tissues and fluids, in relevant environmental compartment.

1.5. Impact on human and animal health

Member States shall evaluate data on human and animal (i.e. species normally fed and kept by humans or food-producing animals) health submitted in accordance with Sections 5 and 6 of Part B of the Annex to Regulation (EU) No 283/2013 and Sections 7 and 8 of Part B of the Annex to Regulation (EU) No 284/2013.

The most important aspects that shall be assessed are:

— infectivity and pathogenicity;

— toxicity of metabolites of concern, safeners, synergists, and relevant impurities;

— relevant antimicrobial activity of metabolites present in the plant protection product;

— susceptibility to relevant antimicrobial agents to ensure the availability of sufficient treatment options in case of an opportunistic infection.

These aspects comprise a complex set of interactions between micro-organisms and the hosts, and need to be assessed in an integrated way and applying a weight of evidence approach.

An assessment of infectivity and pathogenicity is always necessary.

1.5.1. Effects on human or animal health arising from the plant protection product

1.5.1.1. Availability of sufficient treatment options against the micro-organism contained in the plant protection product shall be evaluated.

1.5.1.2. Member States shall evaluate infectivity and pathogenicity of the micro-organism and toxicity of metabolites of concern and relevant impurities. This evaluation shall take into consideration the following information: (a) the available information on infectivity and pathogenicity (e.g. based on biological properties, peer-reviewed literature, animal studies performed by the applicant) as provided for in Part B of the Annex to Regulation (EU) No 283/2013. For micro-organisms, infectivity and pathogenicity tests on animals may not always be suitable for extrapolation to humans due to differences between humans and test animals (e.g. immune system, microbiome). Micro-organisms might have a narrow host range, hence it cannot always be assumed that a micro-organism that does cause disease in the animals tested has the same result in humans, and vice-versa. Information available and provided by the applicant, as required in points 2.1, 2.3, 2.4, 2.6 and 5.1 of Part B of the Annex to Regulation (EU) No 283/2013, and/or retrieved from any other reliable sources (e.g. Qualified Presumption of Safety, peer-reviewed literature) may provide robust and reliable scientific indication on infectivity and pathogenicity of the micro-organism. Where an applicant provides a summary of information already available on infectivity and pathogenicity